RAB12-LRRK2 Complex Suppresses Primary Ciliogenesis and Regulates Centrosome Homeostasis in Astrocytes

Xingjian Li1,2, Hanwen Zhu3, Bik Tzu Huang1,4,5

  • 1Department of Neurology, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Insights

Researchers identified RAB12 as a key target of Leucine-rich repeat kinase 2 (LRRK2) in the brain. This interaction regulates cell structure, offering new therapeutic targets for Parkinson's disease (PD).

Area of Science:

  • Cell Biology
  • Neuroscience
  • Structural Biology

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease (PD) through its phosphorylation of RAB GTPases.
  • The specific roles of LRRK2-phosphorylated RAB GTPases in brain function, particularly in relation to PD, are not fully understood.

Purpose of the Study:

  • To identify novel LRRK2 substrates in the brain.
  • To elucidate the function of the RAB12-LRRK2 complex in regulating ciliogenesis and centrosome homeostasis.
  • To provide structural insights into the RAB12-LRRK2 interaction for therapeutic development.

Main Methods:

  • Phosphoproteomics profiling to identify LRRK2 substrates in mouse brains.
  • Cryo-electron microscopy (Cryo-EM) to determine the structure of the RAB12-LRRK2 protein complex.
  • Genetic manipulation (gene deletion) in astrocytes to assess functional consequences.

Main Results:

  • RAB12 was identified as a direct substrate of LRRK2 in mouse brains.
  • The RAB12-LRRK2 complex inhibits primary ciliogenesis and regulates centrosome homeostasis in astrocytes.
  • This regulation involves RAB10 phosphorylation and Rab interacting lysosomal protein like 1 (RILPL1) recruitment.
  • PD-linked LRRK2 mutations' effects on cilia and centrosomes were ameliorated by RAB12 deletion.

Conclusions:

  • The study reveals a novel physiological role for the RAB12-LRRK2 complex in ciliogenesis and centrosome homeostasis.
  • The elucidated structure of the RAB12-LRRK2 complex provides a basis for developing therapeutics targeting PD by modulating this interaction.

Related Concept Videos

Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Assembly of Complex Microtubule Structures01:32

Assembly of Complex Microtubule Structures

Complex microtubule structures are present in resting cells and in dividing cells. In resting cells, they are responsible for maintaining the cellular architecture, tracks for intracellular transport, positioning of organelles, assembly of cilia and flagella. They mediate the bipolar spindle assembly for chromosomal segregation and positioning of the cell division plate in dividing cells. The formation of microtubule complex structures depends on the cell type, cell stage, and cell function.
1.8K